Atilotrelvir
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Atilotrelvir (development code GST-HG171) is a drug for the treatment of COVID-19. It has broad-spectrum anti-SARS-CoV-2 activity against different variants (including WT, β, δ, and omicron). In combination with ritonavir, it was approved for use in China in 2023.
Atilotrelvir (development code GST-HG171) is a drug for the treatment of COVID-19. It has broad-spectrum anti-SARS-CoV-2 activity against different variants (including WT, β, δ, and omicron). In combination with ritonavir, it was approved for use in China in 2023.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1371307141 under CC BY-SA 4.0; modifications have been made.